FDA Orange Book
Generic for Namzaric
Namzaric contains memantine and donepezil. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Namzaric is memantine and donepezil. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Namzaric and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Namzaric products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, extended release, oral | 10MG;14MG | Marketed (Rx) | AB | 3 | AB |
| capsule, extended release, oral | 10MG;21MG | Marketed (Rx) | AB | 2 | AB |
| capsule, extended release, oral | 10MG;28MG | Marketed (Rx) | AB | 3 | AB |
| capsule, extended release, oral | 10MG;7MG | Marketed (Rx) | AB | 1 | AB |
NDA 206439, held by ABBVIE INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic memantine and donepezil
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| AMNEAL PHARMACEUTICALS LLC | 208328 | AB (A-rated, therapeutically equivalent) | January 27, 2017 | 10MG;14MG, 10MG;21MG, 10MG;28MG, 10MG;7MG |
| ANI PHARMACEUTICALS INC | 208237 | AB (A-rated, therapeutically equivalent) | December 15, 2023 | 10MG;21MG |
| MACLEODS PHARMACEUTICALS LTD | 208672 | AB (A-rated, therapeutically equivalent) | July 15, 2025 | 10MG;14MG, 10MG;28MG |
| XIAMEN LP PHARMACUETICAL CO LTD | 216901 | AB (A-rated, therapeutically equivalent) | July 15, 2025 | 10MG;14MG, 10MG;28MG |
Namzaric patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 8039009 | March 24, 2029 | Method of use | U-1641 | 206439 |
| 8039009*PED | September 24, 2029 | Method of use | None | 206439 |
| 8058291 | December 5, 2029 | Method of use | U-1641 | 206439 |
Namzaric NDC codes
Questions
Is there a generic for Namzaric?
Yes. The generic name for Namzaric is memantine and donepezil. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Namzaric?
The active ingredient in Namzaric is memantine and donepezil, per the FDA Orange Book.
When does the Namzaric patent expire?
The last patent listed for Namzaric in the Orange Book expires December 5, 2029. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.